Vogelbusch Biocommodities GmbH, Österreich
Engineering and construction of bioprocess plants with proprietary technology for the production of alcohol, yeast, vinegar, citric acid, gluconic, glucose and HFS. more
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Engineering and construction of bioprocess plants with proprietary technology for the production of alcohol, yeast, vinegar, citric acid, gluconic, glucose and HFS. more
SMB chromatography is widely associated with multiple columns, complex set-up and difficult handling. The Vogelbusch single column unit shows SMB can be different. more
Vogelbusch GmbH has applied for a patent for a highly-efficient chromatographic separation principle. The process adapts the separation process known as "simulated moving bed" to the specific needs of pharmaceutical companies. A prototype was presented to an audience of experts for the first time at more
Vogelbusch GmbH, which is based in Vienna (Austria), announced that it has applied for a patent for an efficient fermentation process for the high-yield extraction of bioethanol from materials containing hemicellulose. Working in partnership with the Institute of Biotechnology and Biochemical Engine more
Suchen & Finden Login Kurallar ve Koşullar Künye (Yasal Uyarı) Site haritası Home İSE Şirket Faaliyet alanımız Hizmetler Sistemler Ekip Avantajlar İSE’nin özelliklerinin özeti Kooperasyon Hizmetler Kalite Kontrol Otomasyon Elektrik ve MSR Software Fabrika kabul testi Faaliyete geçirme Onaylama Bakım more
Concern Brand Corporation Corporate culture Services Companies Competence Center CC Chemie Energy efficiency Services Profile Consulting Basic Engineering Detail Engineering Software Engineering MES Manufacturing On-site Installation Service and Maintenance Branches/References Petrochemicals Paper a more
About us Polymun was founded in 1992 by Prof. Hermann Katinger . It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. These revenues are invested in the propr more